KRYS
NASDAQ · Biotechnology
Krystal Biotech Inc
$340.21
-3.22 (-0.94%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+34.91%
1Y
+136.80%
YTD
+37.79%
Open$339.21
Previous Close$343.43
Day High$346.82
Day Low$337.60
52W High$356.50
52W Low$127.99
Volume—
Avg Volume376.9K
Market Cap10.26B
P/E Ratio45.60
EPS$7.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$263.07
Above
SMA 200
$186.47
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-74.5% upside
Current
$340.21
$340.21
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 383.01M | 971.92M | 894.90M |
| Net Income | 201.61M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 164.39M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |